Home › Funds › MPM BioImpact LLC › ORKA

MPM BioImpact LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

MPM BioImpact LLC reported holding 300,000 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$25.0M, representing 1.92% of its reported portfolio and ranking #25 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.

Latest position (Q3 2026)300.00K sh
Reported value held$24.99M
Portfolio Weight1.92%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's ORKA position evolved

MPM BioImpact LLC first disclosed a stake in ORKA in Q3 2026 at 300,000 shares (US$25.0M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 300.00K $24.99M New

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$345.5M), Fairmount Funds Management LLC (US$308.6M), RTW INVESTMENTS, LP (US$261.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has MPM BioImpact LLC held ORKA?

MPM BioImpact LLC has disclosed ORKA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is MPM BioImpact LLC's current position in ORKA?

As of Q3 2026, MPM BioImpact LLC holds 300.00K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $24.99M, representing 1.92% of its reported portfolio and ranking #25.

Has MPM BioImpact LLC been buying or selling ORKA?

In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in ORKA.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.